Eli Lilly will acquire the WUSTL-linked neurological disease therapy developer in a $135m deal that could top $1.2bn with milestone payments.

Roche and Novo-backed small molecule therapy developer Aligos Therapeutics has floated in an initial public offering priced in the middle of its range.

Nan Fung-backed hearing aid producer Eargo's shares opened at double its IPO price after it floated above its range.

Eli Lilly will acquire the AbbVie-backed neurological disease therapy developer in a $135m transaction that could top $1.2bn with milestone payments.

Instylla, developer of a blood-flow control system, has completed a $25.4m series B round featuring returning investor Ascension Ventures.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

SoftBank has exited the electronic health record platform through a $32.7m acquisition by medical school operator Afya.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Codiak – based on research at Gothenburg and MD Anderson Cancer Center – has succeeded in going public after previously cancelling plans.

The federal development board for Southern Ontario has injected $5m to accelerate the growth potential of TIAP's early-stage health sciences portfolio.